Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

(1→3)-β-d-Glucan: A Biomarker for Microbial Translocation in Individuals with Acute or Early HIV Infection?

Hoenigl M, Pérez-Santiago J, Nakazawa M, de Oliveira MF, Zhang Y, Finkelman MA, Letendre S, Smith D, Gianella S.

Front Immunol. 2016 Oct 3;7:404. eCollection 2016.

2.

Cerebrospinal Fluid (1,3)-Beta-d-Glucan Testing Is Useful in Diagnosis of Coccidioidal Meningitis.

Stevens DA, Zhang Y, Finkelman MA, Pappagianis D, Clemons KV, Martinez M.

J Clin Microbiol. 2016 Nov;54(11):2707-2710. Epub 2016 Aug 24.

3.

(1,3) β-D-Glucan in Bronchoalveolar Lavage of Lung Transplant Recipients for the Diagnosis of Invasive Pulmonary Aspergillosis.

Bhaskaran A, Kabbani D, Singer LG, Prochnow T, Bhimji A, Rotstein C, Finkelman MA, Keshavjee S, Husain S.

Med Mycol. 2017 Feb 1;55(2):173-179. doi: 10.1093/mmy/myw052. Epub 2016 Aug 2.

PMID:
27486213
4.

Detection of (1→3)-β-d-Glucan in Eumycetoma Patients.

Fahal AH, Finkelman MA, Zhang Y, van de Sande WW.

J Clin Microbiol. 2016 Oct;54(10):2614-7. doi: 10.1128/JCM.01478-16. Epub 2016 Jul 20.

5.

Comment on: 1,3-β-d-Glucan contamination of common antimicrobials.

Finkelman MA.

J Antimicrob Chemother. 2016 Oct;71(10):2996-7. doi: 10.1093/jac/dkw237. Epub 2016 Jun 21. No abstract available.

PMID:
27334662
6.

(1→3)-β-d-Glucan in Cerebrospinal Fluid as a Biomarker for Candida and Aspergillus Infections of the Central Nervous System in Pediatric Patients.

Salvatore CM, Chen TK, Toussi SS, DeLaMora P, Petraitiene R, Finkelman MA, Walsh TJ.

J Pediatric Infect Dis Soc. 2016 Sep;5(3):277-86. doi: 10.1093/jpids/piv014. Epub 2015 Mar 19.

7.

Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis.

Petraitiene R, Petraitis V, Bacher JD, Finkelman MA, Walsh TJ.

Med Mycol. 2015 Aug;53(6):558-68. doi: 10.1093/mmy/myv034. Epub 2015 Jun 30.

PMID:
26129890
8.

Utility of measuring (1,3)-β-d-glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection.

Lyons JL, Thakur KT, Lee R, Watkins T, Pardo CA, Carson KA, Markley B, Finkelman MA, Marr KA, Roos KL, Zhang SX.

J Clin Microbiol. 2015 Jan;53(1):319-22. doi: 10.1128/JCM.02301-14. Epub 2014 Nov 5.

9.

Beta-glucan for Pneumocystis pneumonia diagnosis in persons with AIDS: authors' reply.

Wood BR, Komarow L, Zolopa AR, Finkelman MA, Powderly WG, Sax PE.

AIDS. 2013 Nov 28;27(18):2967-8. doi: 10.1097/QAD.0000000000000018. No abstract available.

PMID:
25119691
10.

Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptoms.

Wood BR, Komarow L, Zolopa AR, Finkelman MA, Powderly WG, Sax PE.

AIDS. 2013 Mar 27;27(6):967-72. doi: 10.1097/QAD.0b013e32835cb646.

11.

Serum (1->3)-β-D-glucan measurement in coccidioidomycosis.

Thompson GR 3rd, Bays DJ, Johnson SM, Cohen SH, Pappagianis D, Finkelman MA.

J Clin Microbiol. 2012 Sep;50(9):3060-2. doi: 10.1128/JCM.00631-12. Epub 2012 Jun 12.

12.

Serum galactomannan and (1->3)-β-D-glucan assays for patients with multiple myeloma and Waldenstrom's macroglobulinemia.

Issa NC, Koo S, Lynch RC, Gay C, Hammond SP, Baden LR, Ghobrial IM, Finkelman MA, Marty FM.

J Clin Microbiol. 2012 Mar;50(3):1054-6. doi: 10.1128/JCM.06295-11. Epub 2011 Dec 14.

13.

Does ampicillin-sulbactam cause false positivity of (1,3)-beta-D-glucan assay? A prospective evaluation of 15 patients without invasive fungal infections.

Metan G, Agkus C, Nedret Koc A, Elmali F, Finkelman MA.

Mycoses. 2012 Jul;55(4):366-71. doi: 10.1111/j.1439-0507.2011.02131.x. Epub 2011 Nov 1.

PMID:
22040530
14.

Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease.

Acosta J, Catalan M, del Palacio-Pérez-Medel A, Montejo JC, De-La-Cruz-Bértolo J, Moragues MD, Pontón J, Finkelman MA, del Palacio A.

Eur J Clin Microbiol Infect Dis. 2012 May;31(5):721-31. doi: 10.1007/s10096-011-1365-0. Epub 2011 Aug 3.

PMID:
21811868
15.

Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia.

Sax PE, Komarow L, Finkelman MA, Grant PM, Andersen J, Scully E, Powderly WG, Zolopa AR; AIDS Clinical Trials Group Study A5164 Team.

Clin Infect Dis. 2011 Jul 15;53(2):197-202. doi: 10.1093/cid/cir335.

16.

Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting.

Mohr JF, Sims C, Paetznick V, Rodriguez J, Finkelman MA, Rex JH, Ostrosky-Zeichner L.

J Clin Microbiol. 2011 Jan;49(1):58-61. doi: 10.1128/JCM.01240-10. Epub 2010 Nov 3.

17.

Pneumocystis jirovecii infection: Cell wall (1→3)-β-D-glucan biology and diagnostic utility.

Finkelman MA.

Crit Rev Microbiol. 2010 Nov;36(4):271-81. doi: 10.3109/1040841X.2010.484001. Review.

PMID:
20854193
18.

The absence of Candida albicans in milk samples of women with clinical symptoms of ductal candidiasis.

Hale TW, Bateman TL, Finkelman MA, Berens PD.

Breastfeed Med. 2009 Jun;4(2):57-61. doi: 10.1089/bfm.2008.0144.

PMID:
19500049
19.

Potentiation of Toll-like receptor-induced cytokine production by (1-->3)-beta-D-glucans: implications for the monocyte activation test.

Kikkert R, Bulder I, de Groot ER, Aarden LA, Finkelman MA.

J Endotoxin Res. 2007;13(3):140-9.

PMID:
17621556
20.

Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting.

Smith PB, Benjamin DK Jr, Alexander BD, Johnson MD, Finkelman MA, Steinbach WJ.

Clin Vaccine Immunol. 2007 Jul;14(7):924-5. Epub 2007 May 30.

21.

Reactivity of (1-->3)-beta-d-glucan assay with commonly used intravenous antimicrobials.

Marty FM, Lowry CM, Lempitski SJ, Kubiak DW, Finkelman MA, Baden LR.

Antimicrob Agents Chemother. 2006 Oct;50(10):3450-3.

22.

beta-Glucans in standardized allergen extracts.

Finkelman MA, Lempitski SJ, Slater JE.

J Endotoxin Res. 2006;12(4):241-5.

PMID:
16953976
23.

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.

Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F, Ketchum PA, Wingard J, Schiff R, Tamura H, Finkelman MA, Rex JH.

Clin Infect Dis. 2005 Sep 1;41(5):654-9. Epub 2005 Jul 21.

PMID:
16080087
24.

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.

Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ, Ketchum PA, Finkelman MA, Rex JH, Ostrosky-Zeichner L.

Clin Infect Dis. 2004 Jul 15;39(2):199-205. Epub 2004 Jun 28.

PMID:
15307029
25.

Production of recombinant endotoxin neutralizing protein in Pichia pastoris and methods for its purification.

Paus EJ, Willey J, Ridge RJ, Legg CR, Finkelman MA, Novitsky TJ, Ketchum PA.

Protein Expr Purif. 2002 Nov;26(2):202-10.

PMID:
12406673
26.

Prostatic secretory protein (PSP94) expression in human female reproductive tissues, breast and in endometrial cancer cell lines.

Baijal-Gupta M, Clarke MW, Finkelman MA, McLachlin CM, Han VK.

J Endocrinol. 2000 May;165(2):425-33.

PMID:
10810306
27.

Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosis.

Garde SV, Basrur VS, Li L, Finkelman MA, Krishan A, Wellham L, Ben-Josef E, Haddad M, Taylor JD, Porter AT, Tang DG.

Prostate. 1999 Feb 1;38(2):118-25.

PMID:
9973097
28.

Detection of PSP94 and its specific binding sites in the prostate adenocarcinoma cell line LNCaP.

Yang JP, Finkelman MA, Clarke MW.

J Urol. 1998 Dec;160(6 Pt 1):2240-4.

PMID:
9817377
29.

Identification of binding proteins for PSP94 in human prostate adenocarcinoma cell lines LNCaP and PC-3.

Yang JP, Baijal-Gupta M, Garde SV, Fraser JE, Finkelman MA, Clarke MW.

Prostate. 1998 Apr 1;35(1):11-7.

PMID:
9537594
30.

A new scalable purification procedure for prostatic secretory protein (PSP94) from human seminal plasma.

Baijal-Gupta M, Fraser JE, Clarke MW, Xuan JW, Finkelman MA.

Protein Expr Purif. 1996 Dec;8(4):483-8.

PMID:
8954897
31.

Alternative splicing of PSP94 (prostatic secretory protein of 94 amino acids) mRNA in prostate tissue.

Xuan JW, Chin JL, Guo Y, Chambers AF, Finkelman MA, Clarke MW.

Oncogene. 1995 Sep 21;11(6):1041-7.

PMID:
7566962
32.

Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49.

Milenic DE, Yokota T, Filpula DR, Finkelman MA, Dodd SW, Wood JF, Whitlow M, Snoy P, Schlom J.

Cancer Res. 1991 Dec 1;51(23 Pt 1):6363-71.

33.

Construction and characterization of a single-chain catalytic antibody.

Gibbs RA, Posner BA, Filpula DR, Dodd SW, Finkelman MA, Lee TK, Wroble M, Whitlow M, Benkovic SJ.

Proc Natl Acad Sci U S A. 1991 May 1;88(9):4001-4.

34.

Yeast strain development for extracellular enzyme production.

Finkelman MA.

Bioprocess Technol. 1990;8:185-223. Review. No abstract available.

PMID:
1370014
35.

Pullulan Elaboration by Aureobasidium pullulans Protoplasts.

Finkelman MA, Vardanis A.

Appl Environ Microbiol. 1982 Jul;44(1):121-7.

36.

Simplified microassay for pullulan synthesis.

Finkelman MA, Vardanis A.

Appl Environ Microbiol. 1982 Feb;43(2):483-5.

37.

New Method of Producing Protoplasts of Aureobasidium pullulans.

Finkelman MA, Zajic JE, Vardanis A.

Appl Environ Microbiol. 1980 Apr;39(4):923-5.

Supplemental Content

Loading ...
Support Center